AndreaBozzo/ceres-open-data-index huggingface dataset:
Strengthening Families Through Primary Prevention of Child Maltreatment and Unnecessary Parent-Child Separation

This Information Memorandum (IM) strongly encourages all child welfare agencies and Children’s Bureau (CB) grantees to work together with the courts and other appropriate public and private agencies and partners to plan, implement and maintain integrated primary prevention networks and approaches to strengthen families and prevent maltreatment and the unnecessary removal of children from their families.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 528119: 2-Ethylthio-3-methyl-5-(2-methylbutyl)pyrazine

Chemical compound data from PubChem database. IUPAC Name: 2-ethylsulfanyl-3-methyl-5-(2-methylbutyl)pyrazine. Molecular Formula: C12H20N2S. Molecular Weight: 224.37. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529979: Bicyclo[6.1.0]non-3-ene

Chemical compound data from PubChem database. IUPAC Name: bicyclo[6.1.0]non-3-ene. Molecular Formula: C9H14. Molecular Weight: 122.21. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2023 Uniform Reporting System (URS) Table For Federated States of Micronesia

This is the 2023 Uniform Reporting System (URS) Output Tables for Federated States of Micronesia. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence-based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 528422: Dihydrochalcone, 2',6',4-trihydroxy-4'-methoxy, tris-TMS

Chemical compound data from PubChem database. IUPAC Name: 3-[4-methoxy-2,6-bis(trimethylsilyloxy)phenyl]-1-(4-trimethylsilyloxyphenyl)propan-1-one. Molecular Formula: C25H40O5Si3. Molecular Weight: 504.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526938: 2-Methyl-3-[(2-methyl-3-thienyl)dithio]furan

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-3-[(2-methylthiophen-3-yl)disulfanyl]furan. Molecular Formula: C10H10OS3. Molecular Weight: 242.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526432: 3-Methyl, 3,5-diethyl, heptane

Chemical compound data from PubChem database. IUPAC Name: 3,5-diethyl-3-methylheptane. Molecular Formula: C12H26. Molecular Weight: 170.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Adalimumab-aqvh

YUSIMRY (adalimumab-aqvh) is a prescription biologic drug that blocks tumor necrosis factor, a protein involved in inflammation. It's a monoclonal antibody used to treat autoimmune conditions like rheumatoid arthritis, psoriasis, and inflammatory bowel diseases. Administered as a subcutaneous injection, each dose contains 40 mg of the active ingredient. This information was generated using AI and is provided for informational and research purposes only.
Patent AT-E401383-T1: [Translated] CHIRAL PHOTOISOMERISABLE COMPOUNDS

The invention relates to chiral photoisomerizable compounds of formula (I) wherein X<SUP>1</SUP>, X<SUP>2</SUP>, X<SUP>3</SUP>, X<SUP>4</SUP>, X<SUP>5 </SUP>and X<SUP>6 </SUP>have the meanings given in claim 1 , to liquid crystalline mixtures and polymers containing them, and to the use of chiral photoisomerizable compounds, liquid crystalline mixtures and polymers containing them in optical and electrooptical devices like liquid crystal displays or projection systems, in optical elements like polarizers, retardation films, compensators, color filters or holographic elements, in liquid crystal pigments and colored films or coatings for decorative or security applications, cosmetic and pharmaceutical compositions, in nonlinear optics and optical information storage.
Compound 528750: 1,3,5-Dithiazine, perhydro-4,6-dimethyl-2-pentyl

Chemical compound data from PubChem database. IUPAC Name: 4,6-dimethyl-2-pentyl-1,3,5-dithiazinane. Molecular Formula: C10H21NS2. Molecular Weight: 219.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526427: 3,4,5,6-Tetramethyloctane

Chemical compound data from PubChem database. IUPAC Name: 3,4,5,6-tetramethyloctane. Molecular Formula: C12H26. Molecular Weight: 170.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400934-T1: [Translated] IMPROVED POINTER PROCESSOR MANAGEMENT FOR CHAINED PAYLOAD IN SDH OR SONET FRAMEWORK

A method for improving management of pointer processing for concatenated and/or not concatenated payload in SDH/SONET frames is described. The method comprises the steps of: receiving separate indications about the status of single tributaries, the indications comprising Normal State (NORM), Concatenated State (CONC), Loss of Pointer (LOP) and Alarm Indication Signal (AIS), processing, according to a pure combinatorial logic, the separate indications; and in case one of preset concatenation statuses is identified, such an identified current status of received flow of SDH/SONET frames is promptly declared or, in case no preset concatenation statuses are identified the tributaries are treated as stand alone. Differently from the prior art, the step of declaring a concatenation state is performed independently from a previously stored concatenation level. <IMAGE>
Table 25. 2011-2012 NSDUH Had Serious Thoughts of Suicide in the Past Year, by Age Group and State

Table 25. Had Serious Thoughts of Suicide in the Past Year, by Age Group and State: Percentages, Annual Averages Based on 2011 and 2012 NSDUHs. Results are provided by State and for four age groups: 18 to 25, 26 or older, 18 or older and all persons 18 or older.
Patent AT-E401244-T1: [Translated] ENCODER SELF-CALIBRATION APPARATUS AND METHOD

The disclosed electronic processing apparatus calculates and applies calibrations to sensors that produce quasi-sinusoidal, quadrature signals. The apparatus includes either or both of fixed and programmable electronic circuits. The apparatus includes a circuit to calculate the phase and magnitude corresponding to the two input (quadrature) signals. The apparatus also includes a circuit for accumulating the number of cycles of the input signals. The apparatus also includes a circuit to generate Gain, Offset, and Phase calibration coefficients, wherein the circuit compares the phase space position of the measured phasor with the position of an idealized phasor, the locus of the idealized phasor in phase space being a circle of predetermined radius with no offset. The calculation of the coefficients occurs without user intervention, according to a pre-programmed rule or rules. The apparatus also includes a circuit to apply the Gain, Offset, and Phase calibration coefficients to the measured quadrature signals x i  and y i  according to the formulae    X  i   =    x  i   +   Ox  i   +   P  i   ×   y  i    ×   Gx  i         Y  i   =    y  i   +   Oy  i    ×   Gy  i      where Gx i  and Gy i  are the scaling coefficients, Ox i  and Oy i  are the offset coefficients and P i  is the phase coefficient and where X i  and Y i  are the post-calibration quadrature signals. The apparatus also includes a circuit that creates an output signal representative of the current, calibrated phase. The output signal is either a parallel, digital word or one or more serial pulse trains wherein the total number of pulses produced over time corresponds to the total phase change in the measured signal. The output signal is coded to allow phase decreases as well as phase increases.
Preconceptional factors associated with very low birthweight delivery in East and West Berlin: a case control study

Background
          Very low birthweight, i.e. a birthweight < 1500 g, is among the strongest determinants of infant mortality and childhood morbidity. To develop primary prevention approaches to VLBW birth and its sequelae, information is needed on the causes of preterm birth, their personal and social antecedents, and on conditions associated with very low birthweight. Despite the growing body of evidence linking sociodemographic variables with preterm delivery, little is known as to how this may be extrapolated to the risk of very low birthweight.
        
        
          Methods
          In 1992, two years after the German unification, we started to recruit two cohorts of very low birthweight infants and controls in East and West Berlin for a long-term neurodevelopmental study. The present analysis was undertaken to compare potential preconceptional risk factors for very low birthweight delivery in a case-control design including 166 mothers (82 East vs. 84 West Berlin) with very low birthweight delivery and 341 control mothers (166 East vs. 175 West).
        
        
          Results
          Multivariate logistic regression analysis was used to assess the effects of various dichotomous parental covariates and their interaction with living in East or West Berlin. After backward variable selection, short maternal school education, maternal unemployment, single-room apartment, smoking, previous preterm delivery, and fetal loss emerged as significant main effect variables, together with living in West Berlin as positive effect modificator for single-mother status.
        
        
          Conclusion
          Very low birthweight has been differentially associated with obstetrical history and indicators of maternal socioeconomic status in East and West Berlin. The ranking of these risk factors is under the influence of the political framework.
Patent AT-E401572-T1: [Translated] REAGENT AND METHOD FOR DETECTING ADULTERANTS IN AQUEOUS SAMPLES

This invention relates to a reagent and use of that reagent for detecting adulterants in aqueous samples, particularly in biological specimens such as urine samples using a diazo dye precursor such as N,N diethyl-1,4-phenylene diamine and a reagent such as creatinine to stabilize a colored intermediate formed by the reaction of the diamine with nitrite ions for a period sufficient to allow that color to be recorded and compared with a separate peak formed by a halogen-based oxidizing agent which may be present in solution.
Patent AT-E400335-T1: [Translated] SLIDING BOARD, ESPECIALLY ALPINE SKI OR SNOWBOARD

A snowboard, or alpine ski, has a moulded construction with a lower gliding layer (2), an inner core (5) and with an upper support surface (13) for the binding. The improvement has raised upper edges flanking the binding support surface and with inner facing undercut profiles to provide a grip for the binding. The binding has a sliding fit between the raised profiles and is secured by simple screw fasteners.
Compound 530537: 4-Butylbenzoic acid, tetradecyl ester

Chemical compound data from PubChem database. IUPAC Name: tetradecyl 4-butylbenzoate. Molecular Formula: C25H42O2. Molecular Weight: 374.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400429-T1: [Translated] LOW DISTORTION INTERLAYER

The present invention is in the field of multiple layer glass panels comprising a polymer sheet having desirable surface properties, and more specifically, the present invention is in the field of multiple layer glass panels comprising poly(vinyl butyral) having a finished surface of relatively low waviness and high roughness disposed in contact with poly(ethylene terephthalate) and/or other poly(vinyl butyral) type layers.
Public Health Statistics - Selected underlying causes of death in Chicago, 2006–2010 - Historical

Note: This dataset is historical only and there are not corresponding datasets for more recent time periods. For that more-recent information, please visit the Chicago Health Atlas at https://chicagohealthatlas.org.

This dataset contains the cumulative number of deaths, average number of deaths annually, average annual crude and adjusted death rates with corresponding 95% confidence intervals, and average annual years of potential life lost per 100,000 residents aged 75 and younger due to selected causes of death, by Chicago community area, for the years 2006 – 2010. A ranking for each measure is also provided, with the highest value indicated with a ranking of 1.  See the full description at: https://data.cityofchicago.org/api/views/6vw3-8p6f/files/CqPqfHSv8UUAoXCBjn4_tLqcQHhb36Ih4-meM-4zNzs?download=true&filename=P:\EPI\OEPHI\MATERIALS\REFERENCES\MORTALITY\Dataset_Description_06_10_PORTAL_ONLY.pdf
Anti-HIV-1 activity of cellulose acetate phthalate: Synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles

Background
          Cellulose acetate phthalate (CAP), a promising candidate microbicide for prevention of sexual transmission of the human immunodeficiency virus type 1 (HIV-1) and other sexually transmitted disease (STD) pathogens, was shown to inactivate HIV-1 and to block the coreceptor binding site on the virus envelope glycoprotein gp120. It did not interfere with virus binding to CD4. Since CD4 is the primary cellular receptor for HIV-1, it was of interest to study CAP binding to HIV-1 complexes with soluble CD4 (sCD4) and its consequences, including changes in the conformation of the envelope glycoprotein gp41 within virus particles.
        
        
          Methods
          Enzyme-linked immunosorbent assays (ELISA) were used to study CAP binding to HIV-1-sCD4 complexes and to detect gp41 six-helix bundles accessible on virus particles using antibodies specific for the α-helical core domain of gp41.
        
        
          Results
          1) Pretreatment of HIV-1 with sCD4 augments subsequent binding of CAP; 2) there is synergism between CAP and sCD4 for inhibition of HIV-1 infection; 3) treatment of HIV-1 with CAP induced the formation of gp41 six-helix bundles.
        
        
          Conclusions
          CAP and sCD4 bind to distinct sites on HIV-1 IIIB and BaL virions and their simultaneous binding has profound effects on virus structure and infectivity. The formation of gp41 six-helical bundles, induced by CAP, is known to render the virus incompetent for fusion with target cells thus preventing infection.
Patent AT-E400553-T1: [Translated] 3,6-DISUBSTITUTED AZABICYCLO 3.1.0 - HEXANE DERIVATIVES AS ANTAGONISTS OF THE MUSCARINE RECEPTOR

This invention relates to processes for preparing derivatives of 3,6-disubstituted azabicyclo compounds that can function as muscarinic receptor antagonists, and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors.
Patent AT-E401098-T1: [Translated] LONG-ACTING INTERFERON AND INTERLEUKIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME

Cytokine derivatives are provided bearing functional groups sensitive to mild basic conditions such as fluorenylmethoxycarbonyl (Fmoc) and 2-sulfo-9-fluorenylmethoxycarbonyl (FMS) and pharmaceutical compositions comprising them. Preferred derivates are those in which amino groups of the cytokine are substituted with FMS, for example FMS7-IFN- alpha 2 and FMS3-IL-2. These cytokine derivatives can be administered as inactive or slightly active prodrugs and are capable of undergoing spontaneous regeneration into the parent bioactive drugs under <i>in vivo    physiological conditions and in a hom egenous fashion. The cytokine prodrugs present higher metabolic stability and augmented bioavailability.
Patent AT-E399901-T1: [Translated] METHOD FOR PROCESSING WASTE PAPER CONTAINING WOOD PULP

In a process to recover wood-based waste paper (M), the wastes are converted into a fibrous aqueous suspension (S) which is washed in a second stage (2) to remove foreign bodies or unwanted components. The washed suspension is fractionated in at least a two-stage process into soft fibre (F1) and hard fibre (F2) fractions. The hard fibre fraction is then especially subjected to further grinding and chopping.
2010 CMHS Uniform Reporting System (URS) Output Tables for Kentucky

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2010. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Receipt of Services for Substance Use and Mental Health Issues among Adults: Results from the 2016 National Survey on Drug Use and Health

This report presents data from the 2016 NSDUH for substance use treatment and data from the 2002 through 2016 NSDUHs for mental health service use among adults aged 18 years old or older. Estimates for the receipt of substance use treatment are presented for young adults aged 18 to 25 and for adults aged 26 or older.
FDA Online Label Repository

The drug labels and other drug-specific information on this Web site represent the most recent drug listing information companies have submitted to the Food and Drug Administration (FDA). (See 21 CFR part 207.) The drug labeling and other information has been reformatted to make it easier to read but its content has neither been altered nor verified by FDA. The drug labeling on this Web site may not be the labeling on currently distributed products or identical to the labeling that is approved. Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies described in monographs. Drugs marked 'OTC monograph final' or OTC monograph not final' are not checked for conformance to the monograph. Drugs marked 'unapproved medical gas', 'unapproved homeopathic' or 'unapproved drug other' on this Web site have not been evaluated by FDA for safety and efficacy and their labeling has not been approved. In addition, FDA is not aware of scientific evidence to support homeopathy as effective.
Health Home Quality Measures: Beginning 2013

This dataset contains measures that evaluate the quality of care delivered by Health Homes for the Centers for Medicare & Medicaid Services (CMS) Core Set and Health Home State Plan Amendment (SPA). To support ongoing assessment of the effectiveness of the Health Home model, the CMS has established a recommended Core Set of health care quality measures that it intends to promulgate in the rulemaking process.
The data used in the Health Home Quality Measures are taken from the following sources: 
•	Medicaid Data Mart: Claims and encounters data generated from the Medicaid Data Warehouse (MDW).
•	QARR Member Level Files: Sample of the health plan eligible member’s quality.
•	New York State Delivery System Inform Incentive Program (DSRIP) Data Warehouse: Claims and encounters data generated from the Medicaid Data Warehouse (MDW).

Please refer to the Overview document for additional information.
Accessibility

The Administration for Children and Families (ACF) is committed to providing access to our digital content
  
  

 for individuals with disabilities. To meet this commitment, this site is built to comply with the requirements of Section 508 of the Rehabilitation Act
  
  

. Section 508 requires that individuals with disabilities, who are members of the public seeking information or services from us, have access to and use of information and data that is comparable to that provided to the public who are not individuals with disabilities, unless an undue burden would be imposed on us. Section 508 also requires us to ensure that federal employees with disabilities have access to and use of information and data that is comparable to the access to and use of information and data by federal employees who are not individuals with disabilities, unless an undue burden would be imposed on us.

If you use assistive technology (such as a Braille reader, a screen reader, TTY, etc.) and the format of any material on our websites interferes with your ability to access the information, please contact the Section 508 Coordinator.   Please indicate web address of the requested material, the nature of your accessibility problem, and the preferred format in which to receive the information.

Metadata-only record linking to the original dataset. Open original dataset below.
State Child Abuse and Neglect (SCAN) Policies Database 2023

Other data sources that can be linked with the  SCAN Policies Database include data from the National Child Abuse and Neglect Data System (NCANDS),  the Adoption and Foster Care Analysis and Reporting System (AFCARS), state administrative data, and survey data.  When data from the SCAN Policies Database are linked with other data sources, these data can be used to answer key research questions about how variations in definitions and policies are associated with key aspects of understanding the incidence of child abuse and neglect.

Investigators: Elizabeth C. Weigensberg, PhD - 
Mathematica
Nuzhat Islam, MS - 
Mathematica
Milena Raketic, M.Ed - Mathematica
Mary A. Grider, MBA - 
Mathematica
Jeremy Page, MA - 
Mathematica
Compound 527830: Lys TFA Bu

Chemical compound data from PubChem database. IUPAC Name: butyl 2,6-bis[(2,2,2-trifluoroacetyl)amino]hexanoate. Molecular Formula: C14H20F6N2O4. Molecular Weight: 394.31. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.